Bariatric surgery is efficacious and yields to a high Total Body Weight Loss (TBWL).
BariaTek has raised $1.6M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2023.
BariaTek's investors include Bpifrance.
BariaTek is headquartered in Paris, France.
Bariatric surgery is efficacious and yields to a high Total Body Weight Loss (TBWL).
BariaTek is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BariaTek — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/bariatek. Accessed September 30, 2026.
VCBacked. (2023). BariaTek — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bariatek
{{cite web |title=BariaTek — Funding & Investors |url=https://www.vcbacked.co/company/bariatek |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated